Improving precision and power in randomized trials with a two‐stage study design: Stratification using clustering method.
- Published in:
- Pharmaceutical Statistics, 2023, v. 22, n. 2, p. 396, doi. 10.1002/pst.2279
- By:
- Publication type:
- Article
Works matching IS 15391604 AND DT 2023 AND VI 22 AND IP 2
Results: 13
1
2
A Bayesian method for safety signal detection in ongoing blinded randomised controlled trials.
- Published in:
- Pharmaceutical Statistics, 2023, v. 22, n. 2, p. 378, doi. 10.1002/pst.2278
- By:
- Publication type:
- Article
3
On implementing Jeffreys' substitution likelihood for Bayesian inference concerning the medians of unknown distributions.
- Published in:
- Pharmaceutical Statistics, 2023, v. 22, n. 2, p. 365, doi. 10.1002/pst.2277
- By:
- Publication type:
- Article
4
Web based resource for Statistical Consultants in the Pharmaceutical Industry.
- Published in:
- Pharmaceutical Statistics, 2023, v. 22, n. 2, p. 408, doi. 10.1002/pst.2276
- By:
- Publication type:
- Article
5
Sample size re‐estimation in Phase 2 dose‐finding: Conditional power versus Bayesian predictive power.
- Published in:
- Pharmaceutical Statistics, 2023, v. 22, n. 2, p. 349, doi. 10.1002/pst.2275
- By:
- Publication type:
- Article
6
Statistical modeling approaches for the comparison of dissolution profiles.
- Published in:
- Pharmaceutical Statistics, 2023, v. 22, n. 2, p. 328, doi. 10.1002/pst.2274
- By:
- Publication type:
- Article
7
Should responder analyses be conducted on continuous outcomes?
- Published in:
- Pharmaceutical Statistics, 2023, v. 22, n. 2, p. 312, doi. 10.1002/pst.2273
- By:
- Publication type:
- Article
8
AIDE: Adaptive intrapatient dose escalation designs to accelerate Phase I clinical trials.
- Published in:
- Pharmaceutical Statistics, 2023, v. 22, n. 2, p. 300, doi. 10.1002/pst.2272
- By:
- Publication type:
- Article
9
On the use of extreme value tail modeling for generalized pairwise comparisons with censored outcomes.
- Published in:
- Pharmaceutical Statistics, 2023, v. 22, n. 2, p. 284, doi. 10.1002/pst.2271
- By:
- Publication type:
- Article
10
Regional efficacy evaluation in multi‐regional clinical trials using a discounting factor weighted Z test.
- Published in:
- Pharmaceutical Statistics, 2023, v. 22, n. 2, p. 266, doi. 10.1002/pst.2270
- By:
- Publication type:
- Article
11
Statistical considerations for design and analysis of stability, comparability and formulation tests.
- Published in:
- Pharmaceutical Statistics, 2023, v. 22, n. 2, p. 248, doi. 10.1002/pst.2269
- By:
- Publication type:
- Article
12
Performance of phase‐I dose finding designs with and without a run‐in intra‐patient dose escalation stage.
- Published in:
- Pharmaceutical Statistics, 2023, v. 22, n. 2, p. 236, doi. 10.1002/pst.2268
- By:
- Publication type:
- Article
13
Issue Information.
- Published in:
- Pharmaceutical Statistics, 2023, v. 22, n. 2, p. 233, doi. 10.1002/pst.2236
- Publication type:
- Article